Skip to main content
OpenTrials
Completed

NCT Number: NCT03444207

Effect of Endurance and Endurance-Strength Training on Inflammatory Markers in Women With Abdominal Obesity

The aim of this study was to compare the effects of three months' endurance training and three months' endurance-strength training on inflammatory markers in women with abdominal obesity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Department of Education and Obesity Treatment and Metabolic Disorders; Poznan University of Medical Sciences

Poznan, 60-569, Poland

About this study

Study patients. Written informed consent was obtained from all subjects. The study meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996.

Study design. The study was designed as a prospective randomized trial. Subjects were randomly divided into two groups, A and B, using a randomization list. Both groups performed three month of physical training. Group A underwent endurance training, while group B performed endurance-strength training. Aside from the training, all subjects were instructed to maintain the physical activity and diet that they had been practicing so far. At baseline and after three months of physical training, blood samples for laboratory analyses were taken, anthropometric measurements were performed for both groups.

Intervention. The exercise program lasted three months, with three sessions per week. Women in both groups participated in a total of 36 training sessions. The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity. Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate. Both the endurance and endurance-strength training were comparable in exercise volume; the only difference was the nature of the effort.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • informed written consent;
  • simple obesity;
  • age from 18 to 65 years;
  • body fat content, assessed by electrical bioimpedance, equal to or more than 33%;
  • waist circumference more than 80 cm;
  • stable body weight in the one month prior to the trial.

Exclusion criteria

  • secondary form of excess body mass
  • secondary form of arterial hypertension
  • mean systolic blood pressure > 140 mmHg and/or mean diastolic blood pressure > 90 mmHg;
  • diabetes;
  • ischemic heart disease;
  • stroke;
  • heart failure;
  • history of malignancy;
  • clinically significant heart arrhythmias;
  • a history of use of any dietary supplement;
  • serious liver or kidney damage;
  • abnormal thyroid gland function;
  • clinically significant inflammation, connective tissue disease, or arthritis;
  • nicotine, alcohol, or narcotic abuse;
  • infection;
  • pregnancy, childbirth, or lactation;
  • any other condition that would make participation not in the best interest of the subject, or could prevent the efficacy of the study.

Treatment and study plan

Endurance training

Behavioral

The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity.

Endurance-strength training

Behavioral

Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate.

Primary outcomes

  1. C-reactive protein (CRP) at baseline

    Time frame: At baseline

    Serum concentration of C-reactive protein at baseline

  2. CRP after three months of physical training

    Time frame: after three months of physical training

    Serum concentration of C-reactive protein after three months of physical training

Secondary outcomes

  1. tumor necrosis factor alpha (TNFα) at baseline

    Time frame: at baseline

    Serum concentration of tumor necrosis factor alpha at baseline

  2. TNFα after three months of physical training

    Time frame: after three months of physical training

    Serum concentration of tumor necrosis factor alpha after three months of physical training

  3. soluble receptor 2 of TNF alpha (sTNF R2) at baseline

    Time frame: At baseline

    Serum concentration of soluble receptor 2 of TNF alpha at baseline

  4. sTNF R2 after three months of physical training

    Time frame: after three months of physical training

    Serum concentration of soluble receptor 2 of TNF alpha after three months of physical training

  5. interleukin 6 (IL-6) at baseline

    Time frame: At baseline

    Serum concentration of interleukin 6 at baseline

  6. IL-6 after three months of physical training

    Time frame: after three months of physical training

    Serum concentration of interleukin 6 after three months of physical training

  7. interleukin 1 (IL-1) at baseline

    Time frame: At baseline

    Serum concentration of interleukin 1 at baseline

  8. IL-1 after three months of physical training

    Time frame: after three months of physical training

    Serum concentration of interleukin 1 after three months of physical training

  9. visfatin at baseline

    Time frame: At baseline

    Serum concentration of visfatin at baseline

  10. visfatin after three months of physical training

    Time frame: after three months of physical training

    Serum concentration of visfatin after three months of physical training

  11. Body mass at baseline

    Time frame: At baseline

    Body mass at baseline

  12. Body mass after three months of physical training

    Time frame: after three months of physical training

    Body mass after three months of physical training

  13. Body height at baseline

    Time frame: At baseline

    Body height at baseline

  14. Body height after three months of physical training

    Time frame: after three months of physical training

    Body height after three months of physical training

Sponsors and collaborators

Lead sponsor

Poznan University of Medical Sciences

Other

Registry information

Acronym: ENDOFIT

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Feb 23, 2018
Registry last updated
Feb 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.